𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Range of HPV 16 E7 antibodies in cervical cancer patients, and healthy subjects

✍ Scribed by Alena Suchánková; Martin Krčmář; Viktor Krchňák; Eva Hamšíková; Jir̂ar; Kaňka; Josef Vágner; Vladimír Vonka


Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
170 KB
Volume
51
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


HPV 16 E7 antibody levels in cervical ca
✍ Di Lonardo, Anna; Marcante, Maria Luisa; Poggiali, Federica; Venuti, Aldo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Antibody response to HPV16 E7 oncoprotein may represent a marker of cervical cancer. A HPV16 GST-E7 fusion protein was used in a Western Blot assay to analyse the HPV16 E7 antibody response in 30 patients before and after treatment for cervical carcinoma (stage IIB or IIIB). Patients were treated wi

Uniform distribution of HPV 16 E6 and E7
✍ Ingo Nindl; Knuth Rindfleisch; Beatrix Lotz; Achim Schneider; Matthias Dürst 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB 👁 2 views

High-risk human papillomaviruses (HPV), particularly HPV 16, are associated with invasive cervical cancer (ICC), and persistent high-risk HPV infection is considered to be a marker for progressive cervical intra-epithelial neoplasia (CIN). However, most high-risk, HPV-infected, pre-cancerous lesions

Characterization of humoral immune respo
✍ Miriam Reuschenbach; Tim Waterboer; Keng-Ling Wallin; Jens Einenkel; Joakim Dill 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 241 KB

## Abstract The cellular tumor suppressor p16 is strongly overexpressed in cervical cancers and precancers. We have previously demonstrated that infiltrating T lymphocytes reactive against p16 can be found in cervical cancer patients. Here, we analyzed whether p16 induces humoral immune responses.

Detection of HPV 16 and HPV 18 DNA in th
✍ Patti Kay; Bruce Allan; Lynette Denny; Margaret Hoffman; Anna-Lise Williamson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of HPV DNA in the blood of women with cervical neoplasia. The aim of this study was to determine if HPV DNA could be detec

Skin reactions to human papillomavirus (
✍ Muriel van den Hende; Mariëtte I.E. van Poelgeest; Jeanette M. van der Hulst; Jo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB

## Abstract We have tested the safety and feasibility of a synthetic long peptide‐based HPV16‐specific skin test to detect cellular immune responses to HPV16 E2, E6 and E7 __in vivo__. Women with cervical neoplasia (__n__ = 11) and healthy individuals (__n__ = 19) were intradermally challenged with

Analysis of mutations in the URR and E6/
✍ Amanda L. Stephen; Carol H. Thompson; Martin H. Tattersall; Yvonne E. Cossart; B 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 2 views

High rates of cervical cancer have been reported from parts of China and this may reflect a predominance of cervical infection with particularly aggressive human papillomavirus (HPV) variants. This PCR-based investigation of cervical tumours from Sichuan province in central China demonstrated an HPV